Shizuoka, Japan

Kousuke Harada


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kousuke Harada: Innovator in Anticoagulant Drug Development

Introduction

Kousuke Harada, an inventive mind based in Shizuoka, Japan, has made significant contributions to the field of pharmaceuticals. His work focuses primarily on tricyclic compounds with potential applications in medicine, particularly in the area of anticoagulation. With two patents to his name, Harada's innovations are paving the way for new therapeutic options in the medical industry.

Latest Patents

Kousuke Harada's latest patents revolve around tricyclic compounds characterized by a spiro union. These compounds are represented by a specific formula and are noted for their efficacy as drugs, especially as inhibitors for activated blood coagulation factor X (FXa). This means they could be administered orally and exhibit strong anticoagulant action, making them a promising candidate for therapeutic use. Furthermore, Harada's inventions also relate to a pharmacophore derived from the compound, which aids in the molecular designing of FXa inhibitors.

Career Highlights

Harada is affiliated with Mochida Pharmaceutical Co., Ltd., where his research and development work is focused on advancing pharmaceutical innovations. His dedication to the field has allowed him to gain recognition as an important contributor to the development of drugs that can significantly impact patient care, particularly in anticoagulant therapies.

Collaborations

Throughout his career, Kousuke Harada has collaborated with several esteemed colleagues, including Hidemitsu Nishida and Fumihiko Saitoh. These collaborations foster a productive research environment, driving innovation and enhancing the development of new medicinal compounds.

Conclusion

In summary, Kousuke Harada is an influential inventor whose work in the field of pharmaceuticals, particularly focused on anticoagulant drugs, has the potential to change treatment approaches for blood coagulation disorders. His patents and collaborations illustrate the importance of continued research and innovation in the medical field, contributing to advancements that can improve health outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…